Coelho Rogerio Vivaldi - 03 Jan 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Director
Signature
/s/Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 15:29:53 UTC
Previous filing
05 Nov 2021
Next filing
22 Feb 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney